Death Shot: MRNA Vaccines Designed to Reduce the North American Population

by Dr. Yuhong Dong and Dr. Ann Corson (Epoch Times)


LEFT Fibrous material found in the serum of vaccinated patients Courtesy of Dr Ann Corson CENTER Fibrous clots found in corpses by Richard Hirschman Courtesy of Richard Hirschman RIGHT 40x magnification of a patients blood one month after vaccination The red blood cells are no longer spherical and are clumping as in coagulation and clotting Courtesy of IJVTPR

LEFT: Fibrous material found in the serum of vaccinated patients. (Courtesy of Dr. Ann Corson). CENTER: Fibrous clots found in corpses by Richard Hirschman. (Courtesy of Richard Hirschman) RIGHT: 40x magnification of a patient's blood one month after vaccination. The red blood cells are no longer spherical and are clumping as in coagulation and clotting. (Courtesy of IJVTPR)


Fibrous Clots, Foreign Matter in Blood After COVID Jabs: Is There a Way to Detox?

Recently unusual blood clots as well as metal-like foreign objects found in the vessels of COVID-19 jab recipients have been reported across the country. Both types of substances are unusual and are likely to be harmful to our bodies. What are the potential causes and ramifications of these substances, and is there any chance of reversing the mysterious condition?

The Korea Veritas Doctors (KoVeDocs) for COVID-19 previously found certain foreign materials and moving parasite-like entities in the Pfizer and Moderna mRNA COVID-19 vaccines as those vaccines were warmed to near room temperature.

Subsequently, on March 11 2022, three Korean doctors, Young Mi Lee, Sunyoung Park, and Ki-Yeob Jeon, published findings of similar foreign materials in samples of blood from COVID-19 jab recipients in a paper titled “Foreign Materials in Blood Samples of Recipients of COVID-19 Vaccines” in the International Journal of Vaccine Theory, Practice, and Research.

Epoch Times Photo

Comparisons of foreign materials observed in the Moderna vaccine magnified 400x and in plasma samples from vaccinated patients who received one or more doses of Moderna mRNA COVID-19 vaccine. (“Foreign Materials in Blood Samples of Recipients of COVID-19 Vaccines” in the International Journal of Vaccine Theory, Practice, and Research.)

Unusual materials were found in eight COVID-19 vaccine recipients: six plasma samples contained a multilayered disc of unidentified composition; three samples contained beaded coil-like materials; one plasma sample contained a fibrous bundle of similar appearing beaded foreign material; and a different group of three samples had crystal-like formations of foreign material.

The various shapes and sizes of the foreign materials in centrifuged plasmas of COVID-19 vaccinated individuals closely resembled the shapes and sizes of foreign materials previously observed directly in the vaccines themselves.

The evidence suggests that the foreign materials found in the COVID-19 vaccine recipients in this study were injected into their bodies when they received one or more doses of the COVID-19 vaccines.

Three Italian physicians, all of whom are surgeons—Franco Giovannini, M.D., Riccardo Benzi Cipelli, M.D., and Giampaolo Pisano, M.D.—examined the blood of 1006 symptomatic subjects who had been injected with mRNA COVID-19 vaccines (Pfizer/BioNTech or Moderna) starting from March 2021.

The Italian doctors have repeated the Korean study in a much larger sample and with a more advanced technique, i.e. dark-field microscopic analysis of fresh peripheral blood on a slide, allowing a first and immediate assessment of the health status of a person’s blood, better representing their  overall health status.

One month after the mRNA inoculation, a total of 948 subjects (94 percent of the total studied population) showed blood with aggregation of erythrocytes (red blood cells) and the presence of particles of various shapes and sizes of unclear origin.

This foreign material seemed to collect itself into structures, sometimes forming crystals and other times forming long tubes or fibers.

The foreign structures in the patients’ blood, which had not been there before vaccination, certainly look unusual in the photos included in the study.

Epoch Times Photo

The assembly of particles takes on crystalline features. (Courtesy of IJVTPR)

Epoch Times Photo
This image at 120x magnification (3x magnification digitally produced) hihglights a typical self-aggregating structure in fibro/tubular mode. (Courtesy of IJVTPR)

Epoch Times Photo
Evident tubular formations at 120x magnification in the aggregative phase showing their complex morphology. (Courtesy of IJVTPR)


Epoch Times Photo

These photos are at 40x magnification. At the left side, (a) shows the blood condition of the patient before the inoculation. The right side image, (b) shows the same person’s blood one month after the first dose of Pfizer mRNA “vaccine.” Particles can be seen among the red blood cells which are strongly conglobated around the exogenous particles; the agglomeration is believed to reflect a reduction in zeta potential adversely affecting the normal colloidal distribution of erythrocytes as see at the left. The red blood cells at the right (b) are no longer spherical and are clumping as in coagulation and clotting. (Courtesy of IJVTPR)

Twelve subjects, whose blood was examined with the same method before vaccination, showed a perfectly normal blood appearance under the microscope. The alterations found after the inoculation of the mRNA injections further reinforce the suspicion that the changes were due to the jabs themselves.

These photos are at 40x magnification. At the left side, (a) shows the blood condition of the patient before the inoculation. The right side image, (b) shows the same person’s blood one month after the first dose of Pfizer mRNA “vaccine.” Particles can be seen among the red blood cells which are strongly conglobated around the exogenous particles; the agglomeration is believed to reflect a reduction in zeta potential adversely affecting the normal colloidal distribution of erythrocytes as seen at the left. The red blood cells at the right (b) are no longer spherical and are clumping as in coagulation and clotting. (Courtesy of IJVTPR)

In August 2022, the Italian doctors’ results were published in the same journal as the Korean data.

A German Working Group for COVID Vaccine Analysis, an interdisciplinary working group that undertook the task of analyzing the contents and effects of the novel COVID-19 vaccines, also examined the results.

The aforementioned group consists of independent scientists, including doctors, physicists, chemists, microbiologists, pharmacologists, and alternative health practitioners, supported by lawyers, psychologists, analysts and journalists.

In July 2022, they published their preliminary findings which are quite similar to the findings of the aforementioned studies.

They found visible distinctive particles with complex metallic  structures of different sizes under the dark-field microscope in the blood of all 48 vaccinated people. Those particles were like crystalline formations. Without exception, all of these patients showed peculiarities that were not observed in a single case of unvaccinated subjects.

They have established that the COVID-19 vaccines consistently contain substances with compositions that cannot be determined. Some ingredients have not even been listed as ingredients by the vaccine manufacturers.

Findings From Embalmers: Numerous Long, String-like Fibrous Clots

Several embalmers across the country have been observing many large, and sometimes very long, “fibrous” and “rubbery” clots inside corpses, starting from either 2020 or 2021.

It’s not yet known if the cause of the new clot phenomenon is due to a COVID-19 infection, the vaccines, both, or something different. However, the Korean and Italian studies have provided quite a bit of evidence that it is possible that the COVID-19 jabs cause these strange blood components.

Mike Adams, who runs an ISO-17025 accredited lab in Texas, analyzed clots in August and found them to be lacking iron, potassium, magnesium, and zinc.

The string-like structures differ in size, but the longest can be as long as a human leg and the thickest can be as thick as a pinky finger.

Richard Hirschman, a licensed funeral director and embalmer in Alabama, said “Prior to 2020, 2021, we probably would see somewhere between 5 to 10 percent of the bodies that we would embalm [having] blood clots,” however now, 50 percent to 70 percent of the bodies he sees have clots.

According to experienced embalmers, they are not “normal” post-mortem clots but rather the long tiny strings may have been a contributing factor in the deaths, preventing circulation to those regions.

Epoch Times Photo

Fibrous Clots found in corpses by Richard Hirschman (Courtesy of Richard Hirschman)

Where Do They Come From?

Everyone wants to know what exactly is the cause of these strange, fibrous clots in the blood. But answers may be hard to find, for the manufacturers will not easily disclose the crux of mRNA vaccines.

What we do know is that there are two main components that form these strange things in the blood: metallic elements and protein components. But where do they come from?

Metallic Materials

  • What is graphene?

Graphene oxide (GO)  is derived from graphite by oxidation treatment, which retains the large planar structure and high surface area while introducing hydrophilic groups such as hydroxyl, carboxyl, and epoxy groups. It so becomes a potential carrier platform for bioactive molecules because of unique physicochemical properties, especially the surface that can be easily modified.

GO nanomaterials have been widely used in biomedical fields due to their unique properties such as drug delivery, biological sensor, photodynamic therapy, cancer therapy, antibacterial therapy, and vaccines.

GO has been reported to be used as the delivery vehicle of vaccine antigen, which delivers antigen into dendritic cells (DCs: professional cells reporting signals to T cells). Antigen-loaded GO promotes the cross-presentation of antigen to CD8+T cells, which contributes to the elimination of intracellular pathogens and pathogenic cells after vaccination.

A peer reviewed article has discussed the use of graphene as an adjuvant in vaccines.

On the other hand, an in vitro study showed that GO can activate the immune system by increasing inflammatory factors as well as the proliferation and differentiation of lymphocytes, especially CD8+T cells.

Although GO shows enormous potential in the preparation of new vaccines, its low solubility and poor stability limits its application in the human body.

Furthermore, GO has been shown to be cytotoxic, which may be related to the proteins on its surface; especially since it can damage DNA, a property associated with its inherent chemical characteristics.

GO has been used in flu shots. There is a possibility of graphene oxide being used in the vaccines of COVID for the purpose of increasing the immunogenicity, i.e. the ability of a vaccine to induce an immune response, which is often evaluated by the concentration of neutralizing antibodies in vaccine development trials.

  • Identification of graphene in COVID Vaccines

La Quinta Columna, is a Spanish research team founded by Ricardo Delgado and Dr. José Luis Sevillano.

Dr. Pablo Campra Madrid, PhD in Chemical Sciences and Bachelor in Biological Sciences, associate professor at the University of Almeria, Spain was the first to examine the COVID jabs for metallic materials. He did this at the request of La Quinta Columna.

Dr. Campra Madrid published a report in November 2021 entitled “Detection of Graphene in COVID19 vaccines by micro-raman spectroscopy.” (An English translation of his report can be found here).

He carried out a screening of nanoparticles visible with the optical microscopy in seven random samples of vials of COVID vaccines from four different manufacturers.

Using a technique called micro-RAMAN, Dr. Campra was able to determine the presence of graphene in the samples.

RAMAN infrared spectroscopy is a fast technique that allows us to detect the structure of a material without altering or destroying its properties. It is a modern technique named after its developer Sir C. V. Raman.

Coupled optical microscopy allows the excitation laser to be focused on specific objects and points located on objects, to reinforce the degree of confidence in identifying the nature of the material, and to obtain complementary information on thickness, defects, thermal conductivity and edge geometry of graphene nanocrystalline structures.

Epoch Times Photo
(“Detection of Graphene in COVID19 vaccines by micro-raman spectroscopy.”)

After screening, more than 110 objects were selected for their graphene-like appearance under optical microscopy. Of these, a group of 28 objects were selected due to the compatibility of both images and spectra with the presence of graphene derivatives, based on the correspondence of these signals with those obtained from standards and scientific literature.

The identification of graphene oxide structures can be regarded as conclusive in 8 out of 28 due to the high spectral correlation with the standard. In the remaining 20 objects, images coupled with Raman signals show a very high level of compatibility with undetermined graphene structures, despite the different methods used for detection. .

Here is one sample of the Pfizer vaccine (code: Pfizer 2 WBR UP GO2). The left side photo is  the RAMAN signal which is very similar to the Graphene Oxide as above; the right photo shows the microscopic image of metallic aggregates (at a magnification of 100X).

Epoch Times Photo

(“Detection of Graphene in COVID19 vaccines by micro-raman spectroscopy.”

As a conclusion of his report, which he has made freely available, Dr. Campra makes a call for ongoing studies, discussion, and replication of his work. He also asks other independent researchers, with no conflict of interest or coaction from any institution, to make wider counter-analysis of these products to achieve a more detailed knowledge of the composition and potential health risk of these experimental drugs.

 Public Documentations of mRNA Vaccines

However, neither Pfizer nor Moderna’s public documentation claim their products contain graphene oxide or any other type of metallic components. Nevertheless, there are still potential incidences of quality issues during their mRNA’s manufacturing process, which have been reported from time to time since September 2021.

The issue of mRNA stability is a historically well-known issue in biological research. Unsurprisingly, the quality issues would frequently come up in the pharmaceutical industry, especially for an unstable component such as mRNA.

In the late summer of 2021, metallic contaminants were found in Moderna vaccine vials in Japan. As a result, Japanese authorities suspended the use of three Moderna batches consisting of 1.63 million doses.

Two men aged between 30 and 40 died within days of receiving the Moderna COVID-19 vaccine from the batches in question.

Also, a few weeks later, white floating matter was found in two unused vials of the Pfizer COVID-19 vaccine. Recently, Moderna had to recall 764,900 doses of its COVID-19 vaccine in Europe after contamination was found.

Campra reminds readers that graphene materials are potentially toxic to human beings and the presence of graphene in the COVID-19 vaccines has not been declared in any of the emergency use authorizations.

Proteins

Where do these fibrous proteins come from and how do they form insoluble fiber-like components?

It has been found that these clots are lacking key elements present in healthy human blood, such as iron, potassium, and magnesium, suggesting that they are formed from something other than blood.

The COVID vaccines, after inoculation, instruct the cells to produce large quantities of spike proteins. Normal biochemical and physiological processes are “hijacked” in order to make an abnormal amount of these spike proteins.

Spike proteins are able to form amyloid-like substances, unfold and form a different configuration, contributing to tight string-like bonded structures with longitudinal twisting as well as cross binding- such a process can be made visible through microscopy.

Epoch Times Photo
(“Amyloidogenesis of SARS-CoV-2 Spike Protein” in JACS)

Furthermore, the spike protein can cause blood clots by competitive binding to heparan sulfate; S1 (a part of the spike protein) can induce the production of fibrin resistant to fibrinolysis, leading to unopposed microclot formation.

Interaction Between Metallic Materials, Proteins and Human Body

Finally, there is an interaction between proteins, metals and the human body. It is estimated that approximately half of all our human cellular proteins can bind to metals (pdf).

A good example is the interaction between hemoglobin and iron (Fe). Hemoglobin is a protein found in red blood cells. The main function of hemoglobin is to carry oxygen throughout our body. It also transports some amount of carbon dioxide from different parts of the body to the lungs.

Hemoglobin is made up of four polypeptide subunits, two alpha (α) subunits and two beta (β) subunits. Each of the four subunits contains a heme molecule that contains an iron atom.

Bad examples of interactions between proteins and metals occur with the Tau protein (an abnormal misfolded protein found in Alzheimer’s disease) and metallic elements in the pathogenesis of Alzheimer’s disease.

It has been confirmed that close interactions of the three metal ions Fe2/3+, Cu2+, and Zn2+ with the human tau protein can cause structural changes.

Transmission electron microscopy studies of the tau aggregates formed in the presence of metal ions suggest that the presence of metal ions influences the aggregation process. Fluorescence studies of full-length htau40 in the presence of Cu2+ indicate the formation of reactive oxygen species, which may contribute further to oxidative stress and neuron death.

If the metallic material in the blood of COVID vaccine recipients were possibly proven to be graphene oxide, there are a number of researches which have reported the impact of graphene oxide on biological systems with or without a potential interaction with electromagnetic fields (EMF).

In 2018 a group of Spanish scientists reported that graphene oxide nanosheets disrupt lipid composition, Ca2+ homeostasis and synaptic transmission in primary cortical neurons (pdf).

One Korea study published in 2016 in the journal of Advanced Healthcare Materials, showed that the combination of reduced GO (RGO) and pulsed EMFs enhances the neurogenic and adipogenic differentiation of human alveolar bone marrow stem cells (hABMSCs), synergically increases extracellular matrix (ECM) formation, membrane proteins, and metabolism. The paper also indicates that magnetic-field-irradiated RGO can induce magnetic moments, which then induces electric currents when the magnetic fields change.

Why is graphene or GO so hotly contended? It has many attractive physical properties, such as high conductivity, good transparency and nonlinearity. Graphene is also a promising material to construct reconfigurable miniaturized resonant antennas.

In the 2018 International Japan-Africa Conference on Electronics, Communications and Computations (JAC-ECC), Egyptian scientists (Zainud-Deen, Malhat, and Ghazi) reported that graphene has been used in telecommunication infrastructures.

Their full paper is titled “High Gain Graphene-Based Magneto-Electric Antenna for 5G Communications.”

Even though the interaction between graphene in the body and EMFs is not yet precisely understood, we do know that our living environment is full of various EMF fields emitted by cell phone towers, mobile phones, TVs, radios, electrical appliances, and microwave emitters. Graphene is a metal with excellent conductivity.

These EMFs may have an impact on our health as well. For example, a study published in the Journal of Clinical and Translational Research in October 2021 explored the effects of EMFs on the clinical severity of COVID-19 infections. The authors propose “a substantial overlap in pathobiology” between COVID-19 and wireless communications radiation exposure, especially 5G. They present evidence that clinical progression of COVID-19 could be generated by wireless communication radiation (WCR) exposure.

Throughout the summer of 2021, hundreds of amateur videos circulated on social media of people with metallic objects sticking to their bodies at or close to injection sites, indicating they had developed electromagnetic properties following vaccination. These observations were however quickly dismissed by the mainstream media and scientific community as an adhesive property of natural skin oils. Nevertheless, researchers from the European Forum for Vaccine Vigilance did a study on the electromagnetism of vaccinated persons in Luxembourg which found that magnets indeed adhered to vaccinated people’s skin.

Additionally, the Spanish research institute, La Quinta Columna has presented evidence that some vaccinated people not only present with magnetism but also that graphene toxicity can present with symptoms similar to COVID-19 illness.

A detailed analysis of the COVID-19 vaccines has also revealed the presence of nano routers, tubules, and circuits that may explain why some of those vaccinated emit bluetooth MAC addresses.

Spanish and French researchers have documented MAC addresses coming from the vaccinated but not the unvaccinated. Unfortunately, much of this research is being heavily censored and labeled as false by fact-checkers.

The interaction of graphene inside the human body with EMFs should be thoroughly investigated and the potential harm to human health should be diligently elucidated.

As we have witnessed an extraordinarily wide range of adverse reactions after COVID jabs, perhaps these metals and jelly-like strings in the blood are perhaps key reasons for sudden death, cardiac attack, fatigue, brain fog, or neuropsychological syndrome after vaccination.

Other adverse consequences that have been reported include: autoimmune diseases, weakened immune systems, inflammatory conditions, organ damage, high blood pressure, heart attacks, myocarditis, neurodegenerative diseases, cancer, and shortened life expectancy.

Such a diverse pattern of diseases may conceal the causative role of these abnormal blood forgein bodies and fibrous clots associated with COVID-19 vaccinations may play in these diseases.

A Global Collaboration Is Called to Further Investigation

As doctors who have been observing this pandemic and the vaccination agenda  since the beginning, we have to express our deep concern in relation to these unprecedented findings.

All the scientists who have conducted their own research on this matter have expressed a warning and alerted the global medical community about the seriousness of this matter.

Nobody has ever witnessed such types of abnormal metals in addition to the unusual fibrotic string-like clots in humans.

The first recommendation would be to halt all COVID-19 vaccination programs immediately.

There should be an immediate cessation of and abandonment of any COVID-19 “Vaccine Pass Policy” and any other form of mandate for COVID-19 vaccinations.

People will likely ask what they should do if they have already been vaccinated, and how to determine if they have these components in their blood.

To answer this question, a collaborative worldwide evaluation of COVID-19 vaccine contents, and blood plasma samples of individuals vaccinated with the COVID-19 shots should be undertaken immediately with all due diligence.

Emergency collaborative studies of detoxification protocols for COVID-19 vaccine sequelas should be undertaken.

How Should Vaccinated People Get Rid of These Foreign Metallic Bodies and Spike Protein? There Is Still Hope

First of all, we recommend that all people, particularly those suffering from vaccine related sequela, reduce their exposure to wireless communication radiation and other electromagnetic fields as much as possible.

The most common methods used to reduce the abnormal amount of spike proteins inside our bodies are autophagy-promoting techniques including intermittent fasting, N-acetylcysteine (NAC), natural food ingredients, or meditation.

Detoxing the metallic components inside our bodies might be a bit more difficult as metal does not easily dissolve in our bodies.What kind of methods could be considered to remove those metallic elements from our body?

Supplements: Glutathione, NAC, Vitamins


Glutathione seems to be helpful in removing graphene oxide.

Glutathione is a substance made from the amino acids glycine, cysteine, and glutamic acid. It is produced naturally by the liver and involved in many processes in the body, including tissue building and repair, making chemicals and proteins needed in the body, and for immune system function. We have a natural glutathione reserve in our bodies. This is what gives us a strong immune system.

When glutathione levels are high in the body, we have no problems and our immune system functions well. But when the amount of graphene oxide in the body exceeds the amount of glutathione, it causes the collapse of the immune system and triggers a cytokine storm.

Therefore, graphene oxide might negatively impact the level of glutathione in the body and trigger disease.

N-acetylcysteine (“NAC”) is a supplement that is a known precursor to glutathione and helps the body to make glutathione endogenously, for example when you perform strenuous sports. NAC comes from the amino acid L-cysteine and is used by the body to build antioxidants. Antioxidants are vitamins, minerals, and other nutrients that protect and repair cells from damage. You can get NAC as a supplement or as a prescription drug.

Zinc in combination with NAC are essential antioxidants used to degrade graphene oxide.

Other supplements that can be taken to assist with the removal of graphene oxide are:

  • Astaxanthin
  • Melatonin
  • Milk Thistle
  • Quercetin
  • Vitamin C
  • Vitamin D3

Binders, such as activated charcoal and bentonite clay, among others, are also potentially useful to remove metals and other toxins from the body.


Food and Diet

There are a few foods which can help people excrete metallic elements from our body. Here is one example:

Coriander (Coriandrum sativum L.), a herbal plant belonging to the family Apiaceae, is valued for its culinary and medicinal uses. Due to the presence of a multitude of bioactive components, a wide array of pharmacological activities have been ascribed to this herb, which include antimicrobial, anti-inflammatory, neuro-protective properties. Interestingly, coriander also has potential to detoxify lead.

Mind-body Meditative Practice

Many mind-body exercises are related to the body’s energy field so that they have a special effect in managing these metallic related toxicities.

Here we would like to introduce one type of medication practice that we are most familiar with.

Falun Gong, also known as Falun Dafa, is an ancient Chinese spiritual meditation discipline for overall improvement of body, mind, and spirit. The teachings of Falun Gong, contained in the book Zhuan Falun, emphasize the universal principles of “Truthfulness-Compassion- Forbearance”, or “Zhen-Shan-Ren” in Chinese.

Since its first introduction to the public in 1992, Falun Gong has become popular due to its extraordinary healing effects on people’s physical and mental health. Due to its beneficial health effects, by 1999 there were about 100 million people practicing Falun Gong in mainland China. Now, it is practiced in over 100 countries worldwide.

According to a China government sponsored health survey conducted in 1998 in mainland China, out of 12,731 participants, 93.4 percent had ill conditions, and 49.8 percent had suffered from at least three type of diseases, including hypertension, hyperlipidemia, lung diseases, immune disorders or other difficult to treat, before they began practicing Falun Dafa. Through learning and practicing Falun Dafa, practitioners’ health conditions improved to various degrees. The total effective rate reached 99.1 percent, among which the complete recovery rate was 58.5 percent.

A study presented at the American Society of Clinical Oncology’s (ASCO) annual meeting in 2016 showed the significant benefits of practicing Falun Gong on end stage cancer, including significantly prolonged survival, improved symptoms and quality of life.

In en.minghui.org, the main website for experience sharing of Falun Dafa practitioners, we often read surprising, but real stories that after the surgical operation, metal plates inside people’s bodies of Falun Gong practitioners have been reported to surprisingly disappear.

Here are only a few examples out of many as reported by Falun Gong practitioners:

“My leg was broken when I was hit by a car. … The bone was splintered so the doctor attached a steel plate to hold the bone together. … I asked the doctor to remove the plate. The doctor said it would be very difficult and risky because the surgery could result in infection in the bone and make the situation much worse. … Five years later, I accidentally found that the steel plate in my leg was gone. It disappeared.

“My husband went to deliver some Falun Dafa materials one day, but was hit by a speeding motorcycle. He let the driver go even though his head was bleeding, and one of his elbows was fractured. The doctors implanted a 5-inch long steel plate and nine nails inside his arm. About two years later, he was surprised that it seemed like the plate was gone. So he went to the hospital, where the x-ray confirmed that the steel plate had indeed disappeared.”


”This elderly lady was fraught with many illnesses since she was young and depended on medicine daily. Though her family couldn’t afford to buy enough food, they still tried their best to pay for her medicine.

“During the 20 years of being ill, there were many times she couldn’t get out of bed. …

“But, one day, she started practicing Falun Dafa. After she watched a video recording of Master Li Hongzhi’s lectures on the Fa, she experienced a remarkable physical transformation. She became as energetic as a young person.

“In May 2008, while she was helping her husband take a bath, he fell down and knocked her down too. Her children took her to the hospital and she was diagnosed with a fractured rib. She had surgery and they put in a steel plate. Doctors said that she was too old to endure another surgery to remove the steel plate. …

“She fell again while cooking for her husband during the 2014 Chinese New Year. …

“The doctors said that her bones were all right and only her muscles were hurt slightly. Her son asked them to take an X-ray to be sure.

“The result showed that the nails and steel plate in her leg had disappeared. Her children and grandchildren were astonished. “

You may ask, why? It is suggested that when people practice Falun Gong (pdf), there is a powerful positive energy field that can act to ward off illnesses and maintain fitness.

The human body is also composed of energy fields. When people are meditating or practicing Falun Dafa, high energy matter may be absorbed into our own bodies’ energetic fields and our body substance in this dimension may also change. Those bad substances (metals or toxins) not compatible with high energy fields will be transformed or disappear.

We have many friends who are Falun Dafa practitioners, most of whom are fine despite being vaccinated. Even though we do not have statistical numbers, the bodies of Falun Dafa practitioners have much better self-recovery abilities and seem to be more resistant to vaccine-induced side effects.

The human body is a small universe and there are layers upon layers of molecules, atoms and subatomic structures within it. There is still a lot for us to learn and explore the deeper truth of life in the future. Yet however, modern science can only take us so far, and we believe that it is the hallmark of true scientists to recognize the limitations of science itself and of ourselves. We are human, and playing god is not what we are here to do.

The pandemic has caused a lot of tragedy in the human world, but if we take this chance to open our eyes and discard old views, negative situations can be turned into positive opportunities. Every cloud has a silver lining.

Source:  https://www.theepochtimes.com/fibrous-clots-foreign-matter-in-blood-after-covid-jabs-is-there-a-way-to-detox_4738079.html?utm_source=partner&utm_campaign=TheLibertyDaily

References

https://www.theepochtimes.com/embalmers-have-been-finding-numerous-long-fibrous-clots-that-lack-post-mortem-characteristics_4696015.html

https://www.theepochtimes.com/italian-study-blood-patients-after-mrna-shot_4708049.html

https://ijvtpr.com/index.php/IJVTPR/article/view/37/74

https://ijvtpr.com/index.php/IJVTPR/article/view/47/86

https://www.documentcloud.org/documents/22140176-report-from-working-group-of-vaccine-analysis-in-germany

https://www.theepochtimes.com/embalmers-have-been-finding-numerous-long-fibrous-clots-that-lack-post-mortem-characteristics_4696015.html

https://sci-hub.se/https://doi.org/10.1016/j.actbio.2020.06.009

https://www.laquintacolumna.info/docs/docs/campra-informe-tecnico-en.pdf

https://www.researchgate.net/publication/355684360_Deteccion_de_grafeno_en_vacunas_COVID19_por_espectroscopia_Micro-RAMAN

https://www.dropbox.com/s/tnnq4ftw818chmx/FINAL_VERSIÓN_CAMPRA_REPORT_DETECTION_GRAPHENE_IN_COVID19_VACCINES.pdf?dl=0

https://www.reuters.com/business/healthcare-pharmaceuticals/japan-finds-stainless-steel-particles-suspended-doses-moderna-vaccine-2021-09-01/

https://www.forbes.com/sites/graisondangor/2021/08/28/two-men-in-japan-die-after-covid-19-shots-from-supply-suspected-of-contamination/?sh=3130867f75e4

https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-recalls-thousands-covid-vaccine-doses-2022-04-08/

https://pubs.acs.org/doi/10.1021/jacs.2c03925

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553634/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380922/

http://authors.library.caltech.edu/25052/1/BioinCh.pdf

https://sci-hub.se/https://www.sciencedirect.com/science/article/pii/S0162013418306640?via%3Dihub

https://arxiv.org/pdf/1810.12016.pdf

https://sci-hub.se/10.1002/adhm.201600429

https://ieeexplore.ieee.org/abstract/document/8679535

https://sci-hub.se/10.1109/JEC-ECC.2018.8679535

https://www.theepochtimes.com/schumann-resonances_4630444.html

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580522/

https://www.efvv.eu

https://www.globalresearch.ca/study-electromagnetism-vaccinated-persons-luxembourg/5749516

https://odysee.com/@laquintacolumna:8/ELORIGENDELACOVID19YPROPÓSITOFINAL:0

https://www.richplanet.net/vaccine.php

https://www.bibliotecapleyades.net/ciencia3/ciencia_coronavirusvaccine103.htm

https://gangstalkingmindcontrolcults.com/from-mik-andersons-website-corona2inspect-blogspot-com-translated-to-english/

https://www.theepochtimes.com/covid-aging-brain-reversal_4608393.html

https://www.ftwproject.com/orgonite-blog/how-to-remove-graphene-oxide-from-the-body/

https://pubmed.ncbi.nlm.nih.gov/23281145/

https://en.minghui.org/eng/science_eng/survey98_1eng.htm

https://doi.org/10.1200/JCO.2016.34.15_suppl.e21568

http://en.minghui.org/html/articles/2020/8/8/186251.html

http://en.minghui.org/html/articles/2015/9/5/152394.html

http://en.minghui.org/html/articles/2014/7/7/1939.html

https://falundafa.org/eng/eng/pdf/ZFL2014.pdf
















Pfizer Used Dangerous Assumptions, Rather than Research, to Guess at Outcomes

by Robert W. Chandler, M.D., M.B.A. - Team 5


At the launch of widespread mass inoculation of the public with Pfizer’s mRNA vaccine, BNT162b2, media, physicians’ spokespeople,  and government officials communicated widely that the injected drug would be retained at the injection site muscle tissue and in local lymph nodes. The components were supposed to be metabolized in a day or so, leaving only induced SARS CoV-2 Spike antigen to evoke a therapeutic immune response. A short pulse of drug effect would be followed, they claimed, by limited production of Spike antigen.

However, newly released internal Pfizer documents show that this is not true.  In fact, the injection causes widespread distribution of the material in tissues and this distribution persists for at least two days, and probably much longer. These facts are the exact opposite of what was publicized.

A cluster of FDA-released Pfizer documents — “Final Report: A Tissue Distribution Study of a [3H]-Labelled Lipid Nanoparticle-mRNA Formulation Containing ALC-0315 and ALC-0159 Following Intramuscular Administration in Wistar Han Rats”[https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_185350.pdf], 2.4 NONCLINICAL OVERVIEW [https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M2_24_nonclinical-overview.pdf], “MODULE 2.6.5. PHARMACOKINETICS TABULATED SUMMARY”

[https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M2_26_pharmkin-tabulated-summary.pdf] and the heavily redacted  report “R&D STUDY REPORT No. R-20-0072 – EXPRESSION OF LUCIFERASE-ENCODING MODERNA AFTER I.M. APPLICATION OF GMPREADY ACUITAS LIPID NANOPARTICLE FORMULATION “[https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_R-20-0072.pdf] — all examine tissue distribution of Pfizer’s mRNA vaccine BNT162b2. These documents will be addressed in this report. 

Pfizer Study 185350,” Final Report: A Tissue Distribution Study of a [3H]-Labelled Lipid Nanoparticle-mRNA Formulation Containing ALC-0315 and ALC-0159 Following Intramuscular Administration in Wistar Han Rat”, is one of 21 preclinical Prizer studies involving mice, rats and rhesus macaque non-human primates. Study No. 185350 (Sponsor Reference ALC-NC-0552) was summarized in Pfizer’s “2.4 Nonclinical Overview” and was separately published as a Final Report dated September 24, 2020.

Contained in that document is the following identification of the source:

Test Facility Study No. 185350 REDACTED

SPONSOR: Acuitas, 

6190 Agronomy Road, 

Ste. 402, 

Vancouver, V6T 1Z3 Canada

Sponsor Reference No. ALC-NC-0552

This study was made up  of 42 male and 21 female Wistar Han rats. These rats were injected with 50 or 100 micrograms of BNT162b2 mRNA/LNP (lipid nanoparticle) product labelled with a radioactive tracer material, 3H. Then the rats were sacrificed at intervals of 0.25 hours (15 minutes); 1 hour; 2 hours; 4 hours; 8 hours; and then at 1 and 2 days.

The results of 21 male and 21 female sacrificed rats are presented.

The 100-microgram dose was associated with loss of weight and apparent toxicity in two animals. Unfortunately, the full results of the 100-microgram dose were not presented at all. [https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_185350.pdf, p. 11.]

animal group

This is very important. The 100 microgram dose was considered too toxic to continue to use in the experiment, so the dosage was cut in half. 100 micrograms is the amount in the Moderna injections.

The 50 microgram dose was not safe. One female rat in the 50-microgram dose exhibited piloerection and hunched posture. [https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_185350.pdf, p.19.]

The injection did not stay at the injection site, as we were promised it would. Rather, following injection, the drug was persistent at the injection site, with a third of the dose remaining in muscle tissue for two days in males, and a sixth of the dose remained in females for the same duration.

 injection site

But it did not all stay in the deltoid muscle. From the injection site in the deltoid muscle, mRNA/ Lipid Nanoparticles appeared in blood and plasma fifteen minutes after injection and persisted for the entire duration of the two-day study.


On page 20 of “Final Report: A Tissue Distribution Study of a [3H]-Labelled Lipid Nanoparticle-mRNA Formulation Containing ALC-0315 and ALC-0159 Following Intramuscular Administration in Wistar Han Rat,” the authors note that widespread distribution to “most tissues” occurs by the time of first analysis at 15 minutes after injection. 

There was greater accumulation in blood when compared to plasma, and males generally had higher concentrations than females with lower blood to plasma ratios. No explanation for these differences was offered. 

The major tissues that contained the drug concentration, aside from muscle at the injection site, were identified as being the liver, spleen, adrenal glands, and ovaries. The drug persisted in tissues throughout the duration of the study. The meaning and potential implications of the persistence in tissues was not addressed. [https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_185350.pdf, p. 21.]



Top: highest mean concentrations. Bottom: equivalent % dose.

The next two tables present the overall tissue distribution data from this study. It is reasonable to conclude, thus, that BNT162b2 is distributed throughout the body and persists for at least two days, the duration of the study. [https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_185350.pdf, pp. 7-8.] Tissue specimens were harvested but, unfortunately, no microscopic analysis of these specimens is presented at all, so potential damage to various organs was not evaluated.


A separate pharmacokinetic study, “PF-07302048,” looked at the persistence of the LNP (lipid nanoparticle) transport vessel with a test mRNA inside consisting of LNP coating wrapped around Luciferase mRNA, Figure 2.4.3-1 below. [“R&D STUDY REPORT No. R-20-0072 – EXPRESSION OF LUCIFERASE-ENCODING MODRNA AFTER I.M. APPLICATION OF GMPREADY ACUITAS LIPID NANOPARTICLE FORMULATION”, https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_R-20-0072.pdf.]

The object of this study was to follow the LNP vessel in plasma and liver, and then measure transcription of mRNA inside target organs to validate the delivery model using the bioluminescent properties of Luciferase to identify transcription of the mRNA in target tissues. [https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_R-20-0072.pdf

From this study, we learn that the two measured components of the lipid nanoparticle coating, ALC-0315 [(4-hydroxybutyl) azanediyl]di(hexane-6, 1-diyl) bis (2-hexyldecanooate)] and ALC-0159 (2-[2-(polyethylene glycol)-2000]-N, N-ditetradecylacetamide) are detectable in plasma after 300 hours – that is to say, 12.5 days – which fact raises the issue of how long the contents of the LNP vessel with the mRNA inside persists, and what the implications are of prolonged occupation of host cells by this material. In this study, the BNT162b2 was injected intravenously, accelerating the dissemination of drug. [2.4 NONCLINICAL OVERVIEW, https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M2_24_nonclinical-overview.pdf, p.16.]

Figure 1: From R&D STUDY REPORT No. R-20-0072 – EXPRESSION OF LUCIFERASE-ENCODING MODRNA AFTER I.M. APPLICATION OF GMPREADY ACUITAS LIPID NANOPARTICLE FORMULATION.

This study of the biodistribution of the LNP coating containing Luciferase mRNA found that not only was the mRNA transcribed, but the LNP “vessel” components ALC-0315 and ALC-0159 were retained in the liver and in the plasma for at least 12.5 days. The fate of the Luciferase mRNA was not discussed.

With respect to degradation of the mRNA component, we learn from “2.4 Nonclinical Overview” that Pfizer/Acuitas did not study at all the degradation of the synthetic mRNA in BNT162b2. Similarly, there was no analysis by Pfizer of protein products from BNT162b2 provided. [https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M2_24_nonclinical-overview.pdf, p.20.]



Liver, Spleen, Adrenal glands and Ovaries take up increasing amounts of drug compared with other organs as drug is transported from the injection site by blood and plasma. These data were generated during the 48 hours after injection and these four organs were still accumulating the transferred drug as the experiment ended. Looking at the tissue concentration shown on the y axis, there is 165 microgram lipid equivalent/g drug remaining at the injection site compared with 24 microgram lipid equivalent/g in the liver. This indicates that there may be continued transport from the injection site by blood and plasma well beyond 48 hours when the last animals were sacrificed.

The remaining plots show patterns of drug distribution by blood and plasma and accumulation in organs. Page 1 lists the table of values following injection of radioactive labeling of the LNP component of BNT162b2. Pages 2-16 are plots of drug in Adrenal glands, Bone marrow, Brain, Heart, Kidneys, Liver, Lung, Lymph nodes mandibular and mesenteric, Ovaries, Spleen, Thyroid, Blood and Plasma, Injection site, mandibular lymph nodes vs. mesenteric, and organs with greatest concentrations of the drug.
BNT162b2 has lipid nanoparticles that may have adverse effects on organs and tissues from the lipid component as well as from the mRNA and Spike proteins produced by the mRNA.

Graphical representation of the Pfizer data set allows the reader to get a better understanding of how BNT162b2 flows from the injection site to body organs.
For example, this chart is a plot of tissue concentration first rising steeply at the injection site, left chart, then peaks and declines as the organ systems accumulate concentrations of drug more slowly early then rise over time, right chart.

The final chart on page 19 contrasts ovaries vs testes with approximately 38 times more drug concentration of drug in ovaries. More work is needed to see if there is a connection between menstrual cycle changes as have been reported by Lee, et. al. and elsewhere.

 

Similarly, although the data is incomplete with known outcome in only 27 of 270 pregnancy cases as reported in Pfizer document 5.3.6, the first three months of Adverse Events reporting following widespread release after an Emergency Use Authorization was given by the FDA. What data does exist is disconcerting.

pwerpoint

 Several serious questions are raised by these results:

  1. How long does the BNT162b2 mRNA persist in human tissues? Where does it go in the host cell? How long does it persist inside the cell? What proteins does it produce, and for how long?
  2. Is there any possibility that the BNT162b2 mRNA can be transcribed into DNA, then incorporate into the host genome? If this happens what are the implications?
  3. What are the toxicities from the lipid nanoparticle coating?
  4. Was Pfizer obligated to answer these questions prior to human testing?
  5. Doesn’t proper informed consent require answers to these questions?

Fortunately, answers to these important questions are beginning to appear:

1a. Duration of mRNA in tissues:

In a July 19, 2022, article, the essayist Joomi reviews the topic of how long BNT162 b2 containing mRNA stabilized by a synthetic nucleotide 1N-methyl pseudouridine persists in human tissues. [https://joomi.substack.com/p/were-still-being-misled-about-how?r=chkp3&s=r&utm_campaign=post&utm_medium=web]

A January 2022 human lymph node biopsy study from Stanford University found that the mRNA from both Pfizer and Moderna persists for at least two months, which was the duration of the study. [https://www.cell.com/action/showPdf?pii=S0092-8674%2822%2900076-9]

1b. Proteins produced from BNT162b2 mRNA:

Spike protein is produced after the mRNA is transcribed, and has been found in vivo for at least four months after inoculation. [https://joomi.substack.com/p/were-still-being-misled-about-how?r=chkp3&s=r&utm_campaign=post&utm_medium=web]

Proteins transcribed from the mRNA have not been completely characterized yet. SARS-CoV-2-like Spike protein has been identified as long as four months after inoculation with LNP/mRNA in human exosomes. Toxicity of Spike protein has been described and is reviewed in  the essay “We’re still being misled about how long the mRNA vaccines last in the body.” [https://joomi.substack.com/p/were-still-being-misled-about-how?r=chkp3&s=r&utm_campaign=post&utm_medium=web]

2. What is the fate of BNT162b2 mRNA?

We were informed that “RNA is required for protein synthesis, does not integrate into the genome, is transiently expressed, and is metabolized and is eliminated by the body’s natural mechanisms and, therefore is considered safe.” [Alberer, M. et al. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomized, prospective, first-in-human phase 1 clinical trial. Lancet 90, 1511-1520 (2017).] [Sahin, U. e al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 222-226 (2017).]

However, Alden, et. al., reporting in Current Issues in Molecular Biology 2022, 44, 1115-1126, found BNT162b2 mRNA is reverse transcribed into host DNA beginning six hours after contact with BNT162b2:

“In the BNT162b2 toxicity report, no genotoxicity nor carcinogenicity studies have been provided. Our study shows that BNT162b2 can be reverse transcribed to DNA in liver cell line Huh7, and this may give rise to the concern if BNT162b2-derived DNA may be integrated into the host genome and affect the integrity of genomic DNA, which may potentially mediate genotoxic side effects. At this stage, we do not know if DNA reverse transcribed from BNT162b2 is integrated into the cell genome. Further studies are needed to demonstrate the effect of BNT162b2 on genomic integrity, including whole genome sequencing of cells exposed to BNT162b2, as well as tissues from human subjects who received BNT162b2 vaccination.” [https://www.mdpi.com/1467-3045/44/3/73/htm

This study did not identify DNA transcribed from BNT162b2 mRNA in the host genome following transcription.

However, Zhang et. al., working at Massachusetts Institute of Technology, demonstrated fragments of SARS-CoV-2 mRNA integrated in host DNA in “Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues,” published in 2021 in PNAS, vol. 118, no. 21:

“We show here that SARS-CoV-2 RNA can be reverse-transcribed and integrated into the genome of the infected cell and be expressed as chimeric transcripts fusing viral with cellular sequences. Importantly, such chimeric transcripts are detected in patient-derived tissues.” [https://www.pnas.org/doi/10.1073/pnas.2105968118]

So, scientists are getting close to knowing whether BNT162b2, with its synthetic mRNA, is translated into host DNA and is now a permanent part of human genetic material. If so, the next step is to determine what the implications are.

3. What are the toxicities from the lipid nanoparticle coating?

More research is required to understand the implications of LNP concentration in various organ tissues. It is thought that the PEG component (the polyethylene glycol that coats the LNP) is responsible for anaphylaxis, an often rapid-onset major physiologic event that requires emergency treatment.

4. Was Pfizer obligated to answer these questions prior to human testing?
5. Doesn’t proper informed consent require answers to these questions?

The answers to questions 4 and 5 are “yes,” and the reasons should be obvious now. Basic information about functioning of this mRNA product, BNT162b2, was not known at the time of mass inoculation; and, therefore, a proper risk, benefits and complications discussion was compromised by lack of information. Informed consent is not possible in such a situation.

In conclusion, many negatively consequential shortcuts were made in the development of BNT162b2.

Many omissions in basic research evaluation of BNT162b2 were kept hidden, and there was outright misinformation regarding some of the work that was done.

Assumptions rather than actual research to determine where BNT162b2 goes, what it does, and how long it lasts were made that proved to be false and constitute intentional mis/dis/mal information. We were told that the prodrug, BNT162b2, consisting of a lipid nanoparticle coating of synthetic messenger ribonucleic acid (modRNA), would be deposited in muscle tissue at the injection site and would be migrate to local lymphatics prior to rapid degradation producing Spike antigens for a limited period of time that would produce a desired immune response.

However, Pfizer in its very early Phase 1 trial with mice, rats, and rhesus non-human primates learned that the LNP/mRNA is rapidly disseminated throughout the body and remained in tissues for as long as it was studied, 48 hours for BNT162b2 and 12.5 days for the LNP/Luciferase mRNA test product.

No effort was expended to determine what proteins are produced by the modRNA, what their physiological actions are and how long they are produced as well as what toxicities and adverse events might be anticipated with widespread usage of the LNP/mRNA prodrug.

FOIA requests for internal documents from federal health care agencies, independent review board members, approximately 140 clinical investigators and Pfizer personnel should be made.

Billions of doses were administered to billions of p

eople. The scale of this potentially massive medical misstep is large.

Ten months to develop novel gene therapy for a novel virus is well short of the five to 10 years usually required to develop, test and refine such a product. After billions of doses have been given to children and adults around the world, possibly altering the course of human evolution, the public is now seeing the unfortunate consequences of cutting corners.

This Report was written exclusively for DailyClout by the Members of the War Room / DailyClout Pfizer Documents Research Volunteers.

It should not be copied or republished without permission from DailyClout or a full credit and link to DailyClout.io








I Was Right About The Pfizer CEO!

by Emerald Robinson

Were media outlets paid to publish false "fact checks" in order to smear journalists investigating the deadly COVID vaccines?

Telling the absolute truth is a dangerous business these days — which explains why so few journalists do it anymore. And, as we should all know by now, lies don’t get you banned on Twitter — only the truth gets you “permanently suspended.”

Exhibit A: My tweet about the CEO of Pfizer not being fully vaccinated and having to cancel a trip to Israel over it.


A veritable firestorm erupted on social media — as various frauds and fakes surfaced from the Washington swamp to “fact-check” my tweet. Twitter added a “context warning” to the original tweet. An emergency life-raft for neo-cons and NeverTrumpers called The Dispatch printed a full page rebuttal — which is a giant red flag that certain people were probably taking money from Big Pharma to push the COVID vaccines.

According to Stephen Hayes, I am “a frequent purveyor of bad information” which is practically the highest compliment one can receive in American journalism — when you consider the source.


A year later, Jordan Schachtel bothered to read the Pfizer CEO’s new biography and found, of course, that my tweet was accurate.

It was the “fact check” that was false.


He pointed interested readers to a key passage in a recent Wall Street Journal review of the Pfizer CEO’s new book as well.


Was Pfizer’s PR department making false statements?


Why did The Dispatch try to smear me?

Did The Dispatch receive any funding from Big Pharma or its affiliates? Or from the federal government’s HHS to push the COVID vaccines?

My attorneys will be asking them such questions very soon.







Secret Documents: How Pfizer Covered Up a Flood of Adverse Events

by Stevan Looney


I am a civil trial and appellate attorney in New Mexico, with experience litigating complex matters. My prior essay for DailyClout.io regarding the Pfizer WarRoom Document Review — for which I volunteer as one of 250 attorneys — argued that the documents clearly show evidence of fraud on the part of Pfizer. The latest tranche of documents, released on April 1, 2022, show an equally dramatic revelation: Pfizer knew by February of 2021, that there were had been ‘a large number of adverse events’ in the three months prior

Pfizer also realized that these adverse events were so abundant — and they expected so many more in the months to come — that they advised the FDA that they would hire 2400 additional staffers to deal with the paperwork and data processing they expected due to the anticipated volume of adverse events!  

I reviewed the April 1, 2022, tranche of Pfizer documents the FDA produced pursuant to a federal court order. A document produced on November 17, 2021, was also produced as “reissued” on April 1, 2022. At first glance they appear identical, but they are not. Importantly, information redacted (deleted) from the document produced in the March 2022 production, was included in the April 1, 2022, production. This information is quite telling and some conclusions can be drawn.

The document produced on November 17, 2021, is titled “5.3.6 postmarketing experience.pdf” (November 17, 2021 (984 KB)). That same document in the April 1, 2022, production is titled “reissue_5.3.6 postmarketing experience.pdf”. (April 1, 2022 (958 KB)). The word “reissue” is absent in the November 2021 version. That made me curious, so I did a comparison of the two documents. Here is what one will find on page 6. (The “Bates” number in both documents in the bottom, right-hand corner is “FDA-CBER-2021-5683-0000059.”)

The lengthy paragraph on page 6 of the November 2021 document concerns adverse events reports received by Pfizer as of February 28, 2021. The third sentence of that paragraph in both documents reads: “Due to the large number of spontaneous adverse events reports received for the product [i.e., BNT162b2], the MAH [Marketing Authorization Holder] has prioritized the processing of serious cases, in order to meet expedited regulatory reporting timelines and ensure these reports are available for signal detection and evaluation activity.”

This paragraph ends: “Pfizer has also taken a [sic] multiple actions to help alleviate the large increase of adverse event reports.” Think about that sentence.

“This includes significant technology enhancements, and process and workflow solutions, as well as increasing the number of data entry and case processing colleagues. To date, Pfizer has onboarded approximately 600 additional full-time employees (FTEs). More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021 [emphasis added].”

Also on page 6, under the heading “3. RESULTS”, at “3.1.1 General Overview”, Pfizer discloses in the document produced on April 1, 2022, what it redacted from the same document produced in November of 2021. What Pfizer had produced in April 2022 to take the place of the redacted document in November 2021 document was the fact that for the three-month period beginning December 1, 2020, to February 28, 2021, Pfizer shipped “approximately 126,212,580 [emphasis added] doses of [the FDA emergency use authorized] BNT162b2″ worldwide.

The 126,212,580 figure is redacted in the document produced in November 2021 but is included in the “reissue” document of April 1, 2022.

Likewise, the new, full-time 600 and 1,800 employees, amounting to a total of 2,400 full-time employees, hired to deal with all the anticipated adverse events, are included in the document produced on April 1, 2022, but had been redacted from the same document the FDA had produced in November of 2021. Why the foregoing data were redacted, but then disclosed, we do not know, yet. We do know that the redacted information is damning. What did we learn by comparing the two documents?

First, between December 1, 2020 and February 28, 2021, a period of three months, “a large number of spontaneous adverse events reports” were made to Pfizer regarding the administration to humans of the BNT162b2 “vaccine” for which the FDA had provided emergency use authorization (EUA).

Second, by February 28, 2021, (the date of the document) Pfizer knew that by June of 2021 it would hire at least an additional 2,400 full-time employees to process the adverse events reports Pfizer was receiving. (Appendix 1 to these documents is a list of 1,290 adverse events of special interest (AESI) received in connection with the BNT162b2 “product.” Based upon my research to date, I have found no evidence that these AESI were disclosed publicly prior to November of 2021.)

Lastly, and incredibly, despite having this information, on August 23, 2021, the FDA granted continued EUA status for the BNT162b2 “vaccine” and also approved Bio-N-Tech/Pfizer’s product known as COMIRNATY. Notably, according to the FDA, both the EUA BNT162b2 and the “approved” COMIRNATY are identical and interchangeable products. Thus, it is reasonable to conclude that COMIRNATY also causes “a large number of spontaneous adverse events,” including the adverse events and AESI listed in Appendix 1 to these documents.

In sum, Pfizer did not only apparently commit fraud, but they also compounded the fraud by hiring 2,400 full-time employees to deal with the flood of adverse events that they expected – and yet they told no one about this publicly.

 I will continue to issue analyses of these historic documents.

Mr. Looney is a civil trial and appellate attorney with 42 years of experience, concentrating on complex matters.  Mr. Looney is licensed in New Mexico and practices in all its courts, as well as the United States District Court for the District of New Mexico, the Tenth Circuit Court of Appeals, the US Tax Court and the US Supreme Court.  Mr. Looney served in the U.S. Army as an infantryman from 1970-1972, assigned to the 82nd Arbrn. Div.

Article Source: https://dailyclout.io/how-pfizer-covered-up-anticipated-adverse-events/